XML Financial LLC Sells 320 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

XML Financial LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 11.6% in the third quarter, HoldingsChannel reports. The fund owned 2,447 shares of the financial services provider’s stock after selling 320 shares during the quarter. XML Financial LLC’s holdings in iShares Biotechnology ETF were worth $356,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Jane Street Group LLC bought a new position in shares of iShares Biotechnology ETF in the first quarter worth approximately $14,386,000. Cetera Investment Advisers increased its stake in iShares Biotechnology ETF by 689.4% in the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after buying an additional 79,541 shares in the last quarter. State of Michigan Retirement System raised its holdings in iShares Biotechnology ETF by 150.0% during the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after acquiring an additional 75,000 shares during the period. Aristides Capital LLC purchased a new position in shares of iShares Biotechnology ETF in the second quarter valued at about $9,180,000. Finally, Sanctuary Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the second quarter worth about $8,118,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $148.85 on Monday. iShares Biotechnology ETF has a 12 month low of $113.56 and a 12 month high of $150.57. The stock’s 50 day moving average is $144.84 and its 200 day moving average is $141.27.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.